Cargando…

Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients

BACKGROUND: The understanding of the distribution of hepatitis B virus genotypes and the occult hepatitis B virus infection in hepatocellular carcinoma may shed light into the prevention and treatment of hepatocellular carcinoma. The purpose of the study is to investigate hepatitis B virus genotypes...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jianguo, Gong, Weidong, Cheng, Hong, Wu, Zhiqun, Li, Ding, Wang, Xiangling, Liang, Ping, Zhang, Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152914/
https://www.ncbi.nlm.nih.gov/pubmed/21781311
http://dx.doi.org/10.1186/1743-422X-8-362
_version_ 1782209818029719552
author Lu, Jianguo
Gong, Weidong
Cheng, Hong
Wu, Zhiqun
Li, Ding
Wang, Xiangling
Liang, Ping
Zhang, Ju
author_facet Lu, Jianguo
Gong, Weidong
Cheng, Hong
Wu, Zhiqun
Li, Ding
Wang, Xiangling
Liang, Ping
Zhang, Ju
author_sort Lu, Jianguo
collection PubMed
description BACKGROUND: The understanding of the distribution of hepatitis B virus genotypes and the occult hepatitis B virus infection in hepatocellular carcinoma may shed light into the prevention and treatment of hepatocellular carcinoma. The purpose of the study is to investigate hepatitis B virus genotypes distribution, the high-risk genotypes and the occult infection in north-western China's hepatocellular carcinoma patients. METHODS: Hepatitis B virus genotypes A-D of hepatocellular carcinoma tumor tissues and serum samples in 268 north-western China hepatocellular carcinoma patients were detected by fluorescence polarization assay. The hepatitis B virus genotypes in serum and matched primary tumor tissue samples were compared. Hepatitis B surface antigen and α-fetoprotein in serum were detected. Occult hepatitis B virus infections were analyzed. The relationship between hepatitis B virus genotypes and clinicopathologic characteristics were analyzed statistically using SPSS v.10.0. RESULTS: Intrahepatic hepatitis B virus DNA was detected in 83.6% of 268 patients, whereas serum hepatitis B virus DNA was detected in 78.7%. The hepatitis B virus genotypes in serum were consistent with the results in matched tumor tissue. Intrahepatic hepatitis B virus genotype B and C were detected respectively in 11.6% and 54.5% of the patients. Mixed intrahepatic hepatitis B virus genotypes were detected in 13.4% of 268 patients. There was not mixed hepatitis B virus infection in Edmondonson grade I. The patients with mixed HBV genotypes exhibited statistically significant different Edmondson grade than the patients with single type HBV infection (p < 0.05). Hepatitis B surface antigens were positive in 77.2% of 268 patients. Hepatitis B virus genotype C was detected in 64.7% of occult infected patients. There was no significant differences of patients' ages and α-fetoprotein level in different groups of intrahepatic hepatitis B virus genotypes (p > 0.05). CONCLUSIONS: Hepatitis B virus genotype C was associated closely with the development of hepatocellular carcinoma and the occult hepatitis B virus infection in patients in north-western China. There was a relatively high prevalence of mixed hepatitis B virus infection in Edmondonson grade III-IV.
format Online
Article
Text
id pubmed-3152914
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31529142011-08-10 Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients Lu, Jianguo Gong, Weidong Cheng, Hong Wu, Zhiqun Li, Ding Wang, Xiangling Liang, Ping Zhang, Ju Virol J Research BACKGROUND: The understanding of the distribution of hepatitis B virus genotypes and the occult hepatitis B virus infection in hepatocellular carcinoma may shed light into the prevention and treatment of hepatocellular carcinoma. The purpose of the study is to investigate hepatitis B virus genotypes distribution, the high-risk genotypes and the occult infection in north-western China's hepatocellular carcinoma patients. METHODS: Hepatitis B virus genotypes A-D of hepatocellular carcinoma tumor tissues and serum samples in 268 north-western China hepatocellular carcinoma patients were detected by fluorescence polarization assay. The hepatitis B virus genotypes in serum and matched primary tumor tissue samples were compared. Hepatitis B surface antigen and α-fetoprotein in serum were detected. Occult hepatitis B virus infections were analyzed. The relationship between hepatitis B virus genotypes and clinicopathologic characteristics were analyzed statistically using SPSS v.10.0. RESULTS: Intrahepatic hepatitis B virus DNA was detected in 83.6% of 268 patients, whereas serum hepatitis B virus DNA was detected in 78.7%. The hepatitis B virus genotypes in serum were consistent with the results in matched tumor tissue. Intrahepatic hepatitis B virus genotype B and C were detected respectively in 11.6% and 54.5% of the patients. Mixed intrahepatic hepatitis B virus genotypes were detected in 13.4% of 268 patients. There was not mixed hepatitis B virus infection in Edmondonson grade I. The patients with mixed HBV genotypes exhibited statistically significant different Edmondson grade than the patients with single type HBV infection (p < 0.05). Hepatitis B surface antigens were positive in 77.2% of 268 patients. Hepatitis B virus genotype C was detected in 64.7% of occult infected patients. There was no significant differences of patients' ages and α-fetoprotein level in different groups of intrahepatic hepatitis B virus genotypes (p > 0.05). CONCLUSIONS: Hepatitis B virus genotype C was associated closely with the development of hepatocellular carcinoma and the occult hepatitis B virus infection in patients in north-western China. There was a relatively high prevalence of mixed hepatitis B virus infection in Edmondonson grade III-IV. BioMed Central 2011-07-22 /pmc/articles/PMC3152914/ /pubmed/21781311 http://dx.doi.org/10.1186/1743-422X-8-362 Text en Copyright ©2011 Lu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lu, Jianguo
Gong, Weidong
Cheng, Hong
Wu, Zhiqun
Li, Ding
Wang, Xiangling
Liang, Ping
Zhang, Ju
Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients
title Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients
title_full Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients
title_fullStr Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients
title_full_unstemmed Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients
title_short Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients
title_sort detection of hbv genotypes of tumor tissues and serum by a fluorescence polarization assay in north-western china's hepatocellular carcinoma patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152914/
https://www.ncbi.nlm.nih.gov/pubmed/21781311
http://dx.doi.org/10.1186/1743-422X-8-362
work_keys_str_mv AT lujianguo detectionofhbvgenotypesoftumortissuesandserumbyafluorescencepolarizationassayinnorthwesternchinashepatocellularcarcinomapatients
AT gongweidong detectionofhbvgenotypesoftumortissuesandserumbyafluorescencepolarizationassayinnorthwesternchinashepatocellularcarcinomapatients
AT chenghong detectionofhbvgenotypesoftumortissuesandserumbyafluorescencepolarizationassayinnorthwesternchinashepatocellularcarcinomapatients
AT wuzhiqun detectionofhbvgenotypesoftumortissuesandserumbyafluorescencepolarizationassayinnorthwesternchinashepatocellularcarcinomapatients
AT liding detectionofhbvgenotypesoftumortissuesandserumbyafluorescencepolarizationassayinnorthwesternchinashepatocellularcarcinomapatients
AT wangxiangling detectionofhbvgenotypesoftumortissuesandserumbyafluorescencepolarizationassayinnorthwesternchinashepatocellularcarcinomapatients
AT liangping detectionofhbvgenotypesoftumortissuesandserumbyafluorescencepolarizationassayinnorthwesternchinashepatocellularcarcinomapatients
AT zhangju detectionofhbvgenotypesoftumortissuesandserumbyafluorescencepolarizationassayinnorthwesternchinashepatocellularcarcinomapatients